February 20, 2020
A Delaware federal judge on Thursday rejected Abbott Laboratories' bid to dismiss a suit by former stockholders of Tendyne Holdings Inc. claiming that a merger contract breach cost them $50 million, ruling the amended complaint alleges enough facts to keep the suit alive that the original complaint lacked.
July 19, 2018
Former stockholders of Minnesota-based Tendyne Holdings Inc. sued Abbott Vascular Inc. for breach of a $225 million merger contract Thursday, accusing the latter in a federal lawsuit in Delaware of bungling or scuttling a heart valve development goal worth up to $50 million to the former's investors.